Press Releases from Pharmascroll Research and Consulting Private Limited (18 total)
Pharmascroll offers Social Media Analytics services for Pharmaceutical and Healt …
Pharmascroll, a renowned Market Research and Business Consulting firm, has been offering research services to Healthcare and Pharmaceutical firms since over 3 years. Pharmascroll has published 70+ syndicated reports in multiple disease indications and has served 30+ market research clients in the Pharmaceutical and Healthcare domain. The firm has catered to customers across Global markets including US, Europe and Asian countries. The firm currently offers research services in the areas…
Pharmascroll offering Quality Healthcare and Pharmaceutical Market Research serv …
Pharmascroll, a Market Research and Consulting firm, has been a renowned Syndicated and customized research provider across the Healthcare and Pharmaceutical space. Pharmascroll has generated over 75 market research reports in multiple disease indications and has consulted and researched for several Global clients across multiple areas.
Global Market Research Industry exceeded 44 Bn USD in revenues in 2015 and around 14% of the market research revenues registered across the Globe…
Schizophrenia: Disease Insights & Market Forecasts to 2024 by Pharmascroll
“Schizophrenia: Disease Insights and Market Forecasts to 2024” report delivers an in-depth understanding of the disease, historical & forecasted epidemiology of Schizophrenia disease in the US, EU5 (Germany, France, Italy, Spain, UK), and Japan and the historical & forecasted market size, for Schizophrenia, drug wise in $ sales and patient numbers at global level and in the US, EU5 (Germany, France, Italy, Spain, UK), Australia and Canada till 2024.
Geographies covered:
US
Germany
France
Italy
Spain
UK
Japan
Australia
Canada
Drugs…
Epilepsy: Disease Insights and Market Forecasts to 2024 by Pharmascroll
“Epilepsy: Disease Insights and Market Forecasts to 2024” report delivers an in-depth understanding of the disease, historical & forecasted epidemiology of Epilepsy disease in the US, EU5 (Germany, France, Italy, Spain, UK), and Japan and the historical & forecasted market size, for Epilepsy, drug wise in $ sales and patient numbers at global level and in the US, EU5 (Germany, France, Italy, Spain, UK), Australia and Canada till 2024.
Geographies covered:
US
Germany
France
Italy
Spain
UK
Japan
Australia
Canada
Drugs…
Parkinson’s: Disease Insights and Market Forecasts to 2024 by Pharmascroll
“Parkinson’s: Disease Insights and Market Forecasts to 2024” report delivers an in-depth understanding of the disease, historical & forecasted epidemiology of Parkinson’s disease in the US, EU5 (Germany, France, Italy, Spain, UK), and Japan and the historical & forecasted market size, for Parkinson’s, drug wise in $ sales and patient numbers at global level and in the US, EU5 (Germany, France, Italy, Spain, UK), Australia and Canada till 2024.
Geographies covered:
US
Germany
France
Italy
Spain
UK
Japan
Australia
Canada
Drugs…
Asthma: Disease Insights and Market Forecasts to 2024 by Pharmascroll
“Asthma: Disease Insights and Market Forecasts to 2024” report delivers an in-depth understanding of the disease, historical & forecasted epidemiology of Asthma disease in the US, EU5 (Germany, France, Italy, Spain, UK), and Japan and the historical & forecasted market size, for Asthma, drug wise in $ sales and patient numbers at global level and in the US, EU5 (Germany, France, Italy, Spain, UK), Australia and Canada till 2024.
Geographies covered:
US
Germany
France
Italy
Spain
UK
Japan
Australia
Canada
Drugs…
COPD: Disease Insights and Market Forecasts to 2024 by Pharmascroll
“COPD: Disease Insights and Market Forecasts to 2024” report delivers an in-depth understanding of the disease, historical & forecasted epidemiology of COPD disease in the US, EU5 (Germany, France, Italy, Spain, UK), and Japan and the historical & forecasted market size, for COPD, drug wise in $ sales and patient numbers at global level and in the US, EU5 (Germany, France, Italy, Spain, UK), Australia and Canada till 2024.
Geographies covered:
US
Germany
France
Italy
Spain
UK
Japan
Australia
Canada
Drugs…
Cystic Fibrosis: Disease Insights and Market Forecasts to 2024 by Pharmascroll
“Cystic Fibrosis: Disease Insights and Market Forecasts to 2024” report delivers an in-depth understanding of the disease, historical & forecasted epidemiology of Cystic Fibrosis disease in the US, EU5 (Germany, France, Italy, Spain, UK), and Japan and the historical & forecasted market size, for Cystic Fibrosis, drug wise in $ sales and patient numbers at global level and in the US, EU5 (Germany, France, Italy, Spain, UK), Australia and Canada…
Alzheimer’s: Disease Insights and Market Forecasts to 2024 by Pharmascroll
“Alzheimer’s: Disease Insights and Market Forecasts to 2024” report by Pharmascroll delivers an in-depth understanding of the disease, historical & forecasted epidemiology of Alzheimer’s disease in the US, EU5 (Germany, France, Italy, Spain, UK), and Japan and the historical & forecasted market size, for Alzheimer’s, drug wise in $ sales and patient numbers at global level and in the US, EU5 (Germany, France, Italy, Spain, UK), Australia and Canada till…
PPMS and SPMS: Epidemiology and Market Forecasts to 2030
Multiple Sclerosis is an autoimmune disorder that happens in the Central nervous system of the body. Multiple Sclerosis involves the brain, optic nerves and the spinal cord and leads to the destruction of the insulation layer, Myelin, which covers the nerve fibers in the CNS.
SPMS: Epidemiology and Market Forecasts to 2030
SPMS is characterized by a continuous increase in disability and worsening of symptoms with or without the period of relapses…
Pharmascroll expands its Market Research offerings to multiple Disease Areas
Pharmascroll, a Pharmaceutical market research and business consulting firm, has announced expanding its Market Research offerings to multiple indications across various disease areas. Pharmascroll launched its operations in June 2017, and since then has been offering quality Market Research services in the Neuroscience indications. The company on the back of its successful engagement with Market Research clients and enhanced capabilities has now decided to expand its operations across other indications…
Secondary Progressive MS – Pharmascroll Report predicts increase in market act …
Multiple Sclerosis is an autoimmune disorder that happens in the Central nervous system of the body. Multiple Sclerosis involves the brain, optic nerves and the spinal cord and leads to the destruction of the insulation layer, Myelin, which covers the nerve fibers in the CNS.
SPMS is characterized by a continuous increase in disability and worsening of symptoms with or without the period of relapses and remissions. As per the latest…
Pharmascroll launches Quality Focused Pharmaceutical Market Research services at …
Pharmascroll, a Market Research and Consulting firm registered and launched in June 2017, has been a renowned Syndicated research provider in Pharmaceutical space. Pharmascroll has generated over 30 market research reports in multiple disease indications. In addition to the Syndicated Research Business, Pharmascroll has now announced entry into the Pharma Market Research Business for the Pharmaceutical firms researching and operating in Chronic disease indications.
Global Market Research Industry exceeded 44 Bn…
Pharmascroll launches operations in Customized Pharmaceutical Marketing Research
Pharmascroll, a Market Research and Consulting firm registered and launched in June 2017, has been a renowned Syndicated research provider in Pharmaceutical space. Pharmascroll has generated over 30 market research reports in multiple disease indications including Secondary Progressive Multiple Sclerosis, Primary Progressive Multiple Sclerosis and Migraine disease indications in less than a year of the launch of company. The reports generated by the company are extensive covering the disease insights,…
Pharmascroll Research & Consulting and Market Publishers Ltd Sign Partnership Ag …
Market Publishers Ltd and Pharmascroll Research and Consulting signed a partnership agreement for quality market research promotion on Internet. MarketPublishers.com is now authorised to distribute and sell research reports elaborated by Pharmascroll.
Commenting on the agreement, Natalie Aster, Assistant Manager at Partners Department, said: “Pharmascroll is a renowned provider of diligent business advisory and market research into the pharmaceutical domain with a specific focus on chronic disease indications prevalent the world…
Secondary Progressive MS – Majority MS patients progress to SPMS indicating hu …
Multiple Sclerosis is an autoimmune disorder that happens in the Central nervous system of the body. Multiple Sclerosis involves the brain, optic nerves and the spinal cord and leads to the destruction of the insulation layer, Myelin, which covers the nerve fibers in the CNS.
SPMS is characterized by a continuous increase in disability and worsening of symptoms with or without the period of relapses and remissions. As per the latest…
Migraine – Launch of new molecules to further enhance treatment opportunities
Migraine is a neurological disorder which is often characterized by moderate to severe pain on one side of the head. Migraine attacks can be very intimidating and vary in range and frequency for different patients.
Migraine is known to be one of the three most prevalent diseases in the world. As per the latest report of Pharmascroll, Migraine- A Detailed Overview, the disease is prevalent in around 14% of the…
Primary Progressive MS – Strong pipeline in progressive MS indicates a paradig …
Multiple Sclerosis is an autoimmune disorder that happens in the Central nervous system of the body. Multiple Sclerosis involves the brain, optic nerves and the spinal cord and leads to the destruction of the insulation layer, Myelin, which covers the nerve fibers in the CNS.
Primary progressive multiple sclerosis is primarily characterized by progression of disease activity and the disability amongst the patients. As per the latest report by Pharmascroll, PPMS-…
